• CDK9 inhibitor (A3294): Practical Workflow Guide

  2026-08-31

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for studying CDK9-dependent transcription elongation, positive elongation factor b (P-TEFb) inhibition, and HIV-1 propagation inhibition. It should not be used as a pan-CDK reagent, a universal cytotoxicity control, or a long-term working-solution storage product.

• EZ Cap™ Cas9 mRNA (5-moUTP) for Neurodegeneration

  2026-08-30

  EZ Cap™ Cas9 mRNA (5-moUTP) supports transient CRISPR-Cas9 genome editing for mechanistic neurodegeneration studies. This article translates the Fyn–Stat3 zebrafish findings into practical assay decisions while distinguishing product capabilities from evidence that still requires experimental validation.

• p21-ELP1-Bac Suppresses Glioblastoma Proliferation

  2026-08-29

  The reference study evaluates p21-ELP1-Bac, an elastin-like polypeptide and cell-penetrating peptide delivery system for a p21-derived cell-cycle inhibitor, in three glioblastoma models. Its findings support intracellular delivery and predominantly cytostatic suppression of proliferation, while revealing cell-line differences in sensitivity and apoptosis.

• Ziprasidone Hydrochloride: Mechanism & Research

  2026-08-28

  Ziprasidone HCl is a second-generation antipsychotic agent used in receptor pharmacology and neuroscience research, with reported GOT1 inhibition and exploratory antitumor activity. The strongest translational evidence supports psychiatric use, while pancreatic cancer applications remain preclinical and require independent validation.

• L-Threonine: From Nutrient Flux to Translational Insight

  2026-08-28

  L-Threonine is more than a medium component: it is a tractable variable for studying protein synthesis, amino acid sensing, metabolic flux, and translational assay quality. This perspective connects nutrient engineering with metal-free nanozyme validation while defining practical controls and limits.

• CLCC1 and Herpesvirus Nuclear Egress

  2026-08-28

  A herpes simplex virus 1 CRISPR screen identifies CLCC1 as a host factor required for the membrane fusion step of nuclear egress. CLCC1 loss traps capsid-containing vesicles near the nucleus, reduces viral production, and disrupts nuclear pore complex insertion in uninfected cells, linking viral egress to broader nuclear-envelope morphogenesis.

• Balsalazide disodium: IBD Research Workflows

  2026-08-27

  Balsalazide disodium combines colon-targeted 5-ASA biology with practical applications in inflammation research, immunology assays, animal models, and radiotracer development. This guide translates reported labeling conditions and formulation data into reproducible workflows, controls, and troubleshooting decisions.

• (-)-JQ1: The Control That Makes BET Data Translational

  2026-08-27

  (-)-JQ1 is more than an inactive stereoisomer: it is a strategic control for separating BET bromodomain engagement from downstream transcriptional and survival phenotypes. This article connects rigorous JQ1 assay design with mechanistic lessons from inv(16) AML and the N-MYC/eIF4G1 axis.

• Novel Methylene Ziprasidone Dimer Impurity

  2026-08-26

  Murkute et al. identified and structurally characterized a previously unreported methylene ziprasidone dimer that appeared during scale-up of ziprasidone hydrochloride synthesis. The study demonstrates how preparative HPLC, high-resolution mass spectrometry, and multidimensional NMR can convert an HPLC-UV signal into a defined impurity suitable for process and quality-control assessment.

• CTOP for Reliable μ-Opioid Mechanism Studies

  2026-08-26

  This scenario-based guide explains how CTOP (SKU B5135) can strengthen μ-opioid receptor mechanism studies, especially when viability, proliferation, or pain-related phenotypes are difficult to interpret. It covers experimental controls, peptide handling, circuit-level interpretation, and practical vendor-selection criteria.

• Deferiprone Workflows for Iron-Stress Research

  2026-08-25

  Build controlled iron-deficiency, oxidative-stress, inflammation, and apoptosis assays with water-soluble Deferiprone. This workflow connects enterocyte metabolomics to cancer biology, doxorubicin-response studies, and neurovascular models while emphasizing controls, timing, and troubleshooting.

• Ionic Liquids Tune Coil–Bottlebrush Phase Behavior

  2026-08-24

  Rodriguez, Mahanthappa, and Lodge investigate how coil-bottlebrush diblock copolymers form lyotropic nanostructures in a systematic series of alkylimidazolium ionic liquids. Despite substantial changes in solvent selectivity with alkyl-chain length, the observed morphology depends only weakly on ionic-liquid identity, highlighting the importance of polymer architecture and packing frustration in network-phase design.

• AG-221 (Enasidenib) for IDH2 AML Workflows

  2026-08-24

  Build more informative IDH2-mutant AML experiments by pairing AG-221-mediated 2-hydroxyglutarate reduction with metabolic, differentiation, and resistance readouts. This practical workflow uses isogenic models and CD44-focused assays to distinguish target engagement from nonspecific cytotoxicity.

• Phytol Workflows for RXR and GABA Assays

  2026-08-23

  Phytol supports differentiated workflows for retinoid X receptor signaling, GABAergic transmission modulation, and metabolism-aware PPARα studies. This practical guide covers solvent control, isomer interpretation, dose design, orthogonal readouts, and a cautious translation of polymer self-assembly principles into assay optimization.

• Phosphatase Inhibitor Cocktail 1 Workflow

  2026-08-22

  Protect phosphorylation-dependent biology from the moment tissue or cells are disrupted with a broad-spectrum, DMSO-based inhibitor workflow. This guide translates pressure-overload heart-failure findings into practical Western blot, co-immunoprecipitation, kinase-assay, and phosphoproteomic analysis strategies.

449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page